News and Events
Upcoming Events
September 14, 2026
September 24 ICOC/ARS Meeting
August 28, 2026
Public Comment for Rocket Pharmaceuticals Kresladi Access Plan
August 28, 2026
September 8 Governance Subcommittee Meeting
August 24, 2026
September 3 Communications Subcommittee Meeting
Latest Press Releases
September 25, 2026
CIRM approves more than $195 million to support education, discovery, clinical, and infrastructure awards
September 25, 2026
El CIRM destina $9 millones a Enloe Health para acercar las terapias celulares y génicas a los pacientes del norte de California
September 25, 2026
CIRM awards $9 million to Enloe Health to bring cell and gene therapies closer to patients in Northern California
June 25, 2026
CIRM advances $662 million research budget, the largest annual investment in its history
CIRM’s Blog: The Stem Cellar
The Stem Cellar
- Bridges educational program creates paths to mentorship and medicine November 6, 2026By Holly Alyssa MacCormick Charting a career path is one of the biggest journeys we will undertake in our lifetimes. That’s why the California Institute for Regenerative Medicine (CIRM) created the Bridges to Stem Cell Research and Therapy (Bridges) program. California universities and colleges use Bridges awards to train undergraduate and master’s students in stem […]
- Early CIRM awardee Karl Deisseroth wins Nobel Prize October 26, 2026On Oct. 5, Karl Deisseroth, MD, PhD, and two other scientists won the 2026 Nobel Prize in Physiology or Medicine. The recognition was for the discovery and impact of optogenetics. Optogenetics introduces genes for light-sensitive proteins into cells and then uses light to activate or deactivate cells in living tissue. The California Institute for Regenerative […]
- Tr1X Bio aims to Redefine Cell Therapy for Autoimmune Diseases October 21, 2026Maria Grazia Roncarolo believes her company could redefine treatments for conditions like multiple sclerosis (MS), Crohn’s disease, and other autoimmune diseases. Closer to Cures Dr. Roncarolo, co-founder, president, and head of R&D at San Diego-based Tr1X Bio, said in a recent presentation that her company is modifying the patient’s own immune system to calm cells […]